EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

NAFLD SUMMIT 2019

 

26-28 September 2019 Seville
Close
N. Poster
Poster title
Applicant name
Status
  P02-01 Berberis Aristata, Elaeis Guineensis and Coffea Canephora extracts modulate the Insulin Receptor expression and improve hepatic steatosis in NAFLD patients: a pilot study Valentina Cossiga Received Received
  P01-01 Pilot study of liraglutide on weight and enzymes of obese patients with NAFLD Amr Asem Elfert Received Received
  P05-01 Alcohol and other contributing factors to the burden of liver disease among patients with type-2 diabetes mellitus: a retrospective longitudinal study Lucia PARLATI Received Received
  P01-03 Co-creating Comics to Communicate Non-Alcoholic Fatty Liver Disease - A participatory Research Approach Mireia Alemany i Pagès Received Received
  P05-03 Early immunological modifications of the intestinal barrier in response to a non-alcoholic steatohepatitis-inducing diet Simon Peschard Received Received
  P04-03 Psoriasis and liver damage in HIV-infected subjects M Luisa Montes Ramírez Received Received
  P02-03 Cardiovascular risk assessment in a non-alcoholic fatty liver disease group of romanian patients Dascalu Daciana Nicoleta Received Received
  P03-04 Cannabis consumption prevents hepatic steatosis in psychosis patients PAULA IRUZUBIETA Received Received
  P01-04 Decreased expressions of p70S6K in NK cells of NAFLD patients inhibited F-actin and was correlated with their impaired function Johnny Amer Received Received
  P05-04 The efficacy of L-carnitine administration in nonalcoholic fatty liver disease patients Vasyl Prysyazhnyuk Received Received
  P04-05 Relationship of semiquantitative scoring systems with computered-assisted digital image analysis for quantification of histological features in NAFLD David Marti-Aguado Received Received
  P05-06 The effect of subclinical hypothyroidism on cardiovascular aging in individuals with non-alcoholic fatty liver disease Anastasiia Radchenko Received Received
  P06-06 Evaluating accuracy of serum steatosis and fibrosis scores in a cohort of morbid obese patients Moira Testa Received Received
  P03-07 High-throughput sequencing identified miR-193a as a potential biomarker of non-alcoholic fatty liver disease activity Katherine Johnson Received Received
  P05-09 lncRNA-H19 as an epigenetic biomarker of liver cancer stem cells Ángela Rojas Received Received
  P04-09 Physical activity removes the harmful effects of sedentary behaviours: a prospective look to the Horizon 2020 Foie Gras project in Southern Italy. Emilio Molina Molina Received Received
  P02-10 The relationship of systemic inflammation and endothelial dysfunction with blood lipid spectrum and adipokines levels in patients with NAFLD Iryna Fedzhaga Received Received
  P05-11 Differences in anxiety and depressive symptomatology of NAFLD/NASH patients according to fibrosis stage Jesús Funuyet-Salas Received Received
  P06-11 Elafibranor, a drug candidate for first line NASH monotherapy and a universal backbone for drug combination treatment Axelle Louard Received Received
  P02-12 Mitochondrial GNMT-complex II interaction is recovered by miR-873-5p targeting in NAFLD David Fernández Ramos Received Received
  P06-12 A high-cholesterol diet promotes steatohepatitis and liver tumorigenesis in HCV core gene transgenic mice Xiaojing Wang Received Received
  P02-13 Impact of BMI and Ethnicity on histology as assessed by automated quantitation in liver biopsies of patients with NAFLD Roberta Forlano Received Received
  P05-13 Elevated expressions of Sodium taurocholate co-transporting polypeptide (NTCP) on NK cells impaired their function and contribute to liver fibrosis in NAFLD patients Ahmed Salhab Received Received
  P06-14 The smoking-hemoglobin interaction and risk for advanced fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease Yusuf Yilmaz Received Received
  P05-14 Combined treatment with L-carnitine and nicotinamide riboside improves hepatic metabolism and attenuates obesity, hepatic peroxidation and steatosis kanita salic Received Received
  P04-15 circulating pcsk9 levels correlated with advanced disease in patients with biopsy-proven non alcoholic fatty liver disease Rocío Muñoz Hernández Received Received
  P03-15 Nuclear NFATc1 regulates pro-apoptotic ER stress signaling protein CHOP, and progresses NAFLD to NASH Muhammad Umair Latif Received Received
  P01-15 Liraglutide improves NASH and metabolic disorders in a 3-week diet-induced NASH mouse model Francois Briand Received Received
  P06-16 Coping strategies and fibrosis: a psychological approach to NAFLD Jesús Funuyet-Salas Received Received
  P02-16 Propionic acid intervention in obese Ldlr-/-.Leiden mice attenuates NASH development, but negatively affects cognition Eveline Gart Received Received
  P04-16 The co-stimulatory signals mediated by icos-icosl dyad promote the evolution of non-alcoholic steatohepatitis (nash) Naresh Naik Ramavath Received Received
  P02-17 Comparing computerized tomography indices and liver biopsy in liver transplantation donors for hepatosteatosis Genco Gencdal Received Received
  P01-17 Targeting liver Glutaminase 1 ameliorates NASH by restoring hepatic very-low density lipoproteins triglyceride assembly Jorge Simón Received Received
  P04-17 FAST score for identification of patients with non-alcoholic steatohepatitis (NASH), NAS=4 and significant (F=2) or advanced (F=3) fibrosis Laura Cantu Sanchez Received Received
  P01-18 In patients with Nonalcoholic Fatty Liver Disease significant fibrosis and the active nonalcoholic steatohepatitis is associated with a moderate-high cardiovascular risk at 10 years. Paola Casciato Received Received
  P03-18 Differential therapeutic effects of single and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophage biology Sander Lefere Received Received
  P04-18 Ablation of High mobility group box-1 in intestinal epithelial cells causes intestinal lipid accumulation and reduced non-alcoholic steatohepatitis Natalia Nieto Received Received
  P04-19 Fibrosis impact on quality of life in non-alcoholic fatty liver disease (NAFLD) Jesus Funuyet-Salas Received Received
  P02-19 Osteopontin deficiency promotes liver senescence mediating the onset of non-alcoholic fatty liver disease during aging Beatriz Gómez Santos Received Received
  P01-19 Efficacy and Safety of Saroglitazar in Management of NAFLD patients using Transient Elastography: A Single Center Observational Study Sujit Chaudhuri Received Received
  P01-20 Utility of applying age-adjusted FIB-4 cutoffs in patients with type 2 diabetes Stefano Ciardullo Received Received
  P02-20 Actions of the protease fibroblast activation protein alpha (FAP) on collagens and FGF21 and roles in chronic liver injury Mark Gorrell Received Received
  P05-20 Establishment of an novel non-alcoholic steatohepatitis model using a high fat and cholesterol diet in young rabbits Eiketsu Sho Received Received
  P06-21 Intervention with HE-700 reduces the development of liver inflammation in obese HFD-treated Ldlr-/-.Leiden mice by ameliorating the build-up of hepatic cholesterol Martine C. Morrison Received Received
  P02-22 Risk stratification of patients with non-alcoholic fatty liver disease in primary care using a reflex testing algorithm of FIB-4 and Enhanced Liver Fibrosis Score David Harman Received Received
  P04-23 Suboptimal metabolic control is a risk factor for liver disease progression in patients with type 2 diabetes mellitus Lucia Parlati Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Fri 8:00-15:00
18:47
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
Captcha image
 

EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

NAFLD SUMMIT 2019

 

26-28 September 2019 Seville
HELP LINE
Manage Orders
FAQs


Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 16/09/2019 TO 26/09/2020
Poster
Gallery
Oral Presentation
& Video Gallery
Poster Discussion
Forum
                  
PrintingOnline
Submit your poster online
in powerpoint format

   Poster submission deadline 19/09/2019
Upload Poster
Upload Oral Presentation of Video
Upload
Poster
Upload Oral
Presentation or Video




PosterSessionOnline
Logo Draft
 
Logo Cert